Efficacy and side effects of sevelamer hydrochloride as sole phosphate binder in peritoneal dialysis patients with severe hyperphosphatemia.
Lo
Wai Kei
WK
Department of Medicine, Tung Wah Hospital, Hong Kong. wkloc@hkucc.hku.hk
Cheng
Suk Wai
SW
Ng
Suk Yi
SY
Yip
Terence Pok-Siu
TP
Lam
Man Fai
MF
Tse
Kai Chung
KC
Lui
Sing Leung
SL
D000328:Adult; D000368:Aged; D002614:Chelating Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D054559:Hyperphosphatemia / Q000209:etiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects / Q000379:methods*; D010710:Phosphates / Q000378:metabolism*; D011073:Polyamines / Q000627:therapeutic use*; D011446:Prospective Studies; D000069603:Sevelamer; D016896:Treatment Outcome
D002614:Chelating Agents; D010710:Phosphates; D011073:Polyamines; D000069603:Sevelamer